PRISM BIOLAB
PRISM provider of a therapeutic treatment for non-oncology indications.The company develops therapeutic agents that are used to cure pulmonary fibrosis, cancer and incurable diseases.
PRISM BIOLAB
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2006-11-02
Address:
Fujisawa, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.prismbiolab.com
Total Employee:
11+
Status:
Active
Contact:
0466-53-8383
Total Funding:
42.13 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Font Awesome
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Employees Featured
Founder
Investors List
Eli Lilly
Eli Lilly investment in Series C - PRISM BioLab
Santec Corporation
Santec Corporation investment in Series C - PRISM BioLab
Eisai
Eisai investment in Series C - PRISM BioLab
Healthcare Innovation
Healthcare Innovation investment in Venture Round - PRISM BioLab
Ohara Pharmaceutical
Ohara Pharmaceutical investment in Venture Round - PRISM BioLab
WM Partners
WM Partners investment in Venture Round - PRISM BioLab
DBJ Capital
DBJ Capital investment in Venture Round - PRISM BioLab
CollaboSGK
CollaboSGK investment in Series C - PRISM BioLab
JAFCO
JAFCO investment in Series C - PRISM BioLab
Neostella capital
Neostella capital investment in Series C - PRISM BioLab
Official Site Inspections
http://www.prismbiolab.com Semrush global rank: 3.07 M Semrush visits lastest month: 5.08 K
- Host name: web2.axxiem.com
- IP address: 34.230.198.252
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "PRISM BioLab"
About Us - PRISM BioLab
PRISM BioLab was founded in 2006 by a group of scientists dedicated to creating new drugs based on their technology of peptide mimetic small molecules. More than ten years of …See details»
Prism BioLab - Crunchbase Company Profile & Funding
PRISM BioLab may be growing as it has recently secured funding, which is a strong indicator of investor confidence and can facilitate further research, development, and expansion.See details»
PRISM BioLab Co., Ltd. | LinkedIn
PRISM BioLab Co., Ltd. Biotechnology Fujisawa shi, Kanagawa 618 followers PRISM BioLab is a biotechnology company with PepMetics Technology, a proprietary drug discovery platform.See details»
PRISM BIOLAB - VentureRadar
Develops proprietary small molecule drug discovery technology, focusing on undruggable targets, with two clinical-stage programs for cancer and fibrosis licensed to Japanese pharmaceutical …See details»
PRISM BioLab Company Profile | Management and Employees List
[email protected]: 6: first_last: [email protected]: Your Questions, Our Answers Get Free Access to PRISM BioLab Contacts Info. What is PRISM BioLab revenue? …See details»
PRISM BioLab Co.,LTD Company Description - Stock Analysis
Dec 30, 2024 PRISM BioLab Co.,LTD, a biotechnology company, discovers and develops small molecule inhibitors of protein-protein interaction targets utilizing proprietary PepMetics …See details»
PRISM BioLab - Products, Competitors, Financials, Employees ...
Eisai to Present E7386, co-created by PRISM BioLab and Eisai, at the ESMO (European Society for Medical Oncology) Annual Meeting. Sep 9, 2024. News provided by Share this article …See details»
PRISM BioLab - Tech Company Profile - Gaebler.com Venture …
Www.prismbiolab.com. Email Address. Not Recorded. Company Background Information. Overview. PRISM BioLab was founded in 2006 by a group of scientists dedicated to creating …See details»
PRISM BioLab - Overview, News & Similar companies - ZoomInfo
Jan 26, 2024 PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions Eli Lilly and Company, …See details»
PepMetics® Technology, Drug Discovery Platform
About PRISM BIOLAB. ミッション: PRISM BioLabはPepMetics ® 技術によって「創薬不可能」だった標的を「創薬可能」にし、治療法のなかった病気を治療することを目指しています。. PRISM BioLabは、独自の創薬プラットフォー …See details»
PRISM BioLab Co Ltd, 206A:TYO profile - FT.com - Financial Times
PRISM BioLab Co Ltd (206A:TYO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
PRISM BioLab Company Profile 2024: Stock Performance
Information on stock, financials, earnings, subsidiaries, investors, and executives for PRISM BioLab. Use the PitchBook Platform to explore the full profile.See details»
PRISM BIOLAB - VentureRadar
Website: http://www.prismbiolab.com/ Develops proprietary small molecule drug discovery technology, focusing on undruggable targets, with two clinical-stage programs ...See details»
Ono Enters into a Collaboration Agreement with PRISM BioLab to …
Apr 25, 2024 PRISM BioLab is collaborating on new PPI targets with global and Japanese pharmaceutical companies. PepMetics® targeting CBP/beta-catenin PPIs licensed to Eisai …See details»
株式会社PRISM BioLabの会社情報と資金調達 | NIKKEI COMPASS
Mar 9, 2023 神奈川県藤沢市村岡東2丁目26番1号 ネクセラファーマ株式会社 バイオ創薬 【創薬ベンチャー】肺疾患や認知障害向け医薬品など。後発品も ...See details»
Careers - PRISM BioLab
PRISM BioLab is committed to maximizing the potential of its PepMetics ® Technology, transforming the “undruggable” to “druggable” with the aim of finding cures for the incurable.. …See details»
PRESS RELEASE - prismbiolab.com
[email protected] 26-1, Muraoka-Higashi 2-chome. Fujisawa, Kanagawa 251-8555 www.prismbiolab.com PRESS RELEASE PRISM BioLab, enters into a Joint Research and …See details»
PRISM BioLab-PRISM BioLab Co.,Ltd-企业详情-InvestGO数据库 …
Dec 31, 2005 查看医药魔方InvestGO®数据库PRISM BioLab的公司信息。PRISM BioLab（PRISM BioLab Co.,Ltd），公司简介：PRISM BioLab was founded in 2006 by a …See details»
News - PRISM BioLab
Oct 23, 2024 On Wednesday, November 13, 2024, our CTO, Toma, delivered a presentation at the symposium titled "Chemistry...See details»